Clinical trials recruiting in Rivoli, Italy

Phase breakdown

Conditions recruiting in Rivoli, Italy

Recruiting trials in Rivoli, Italy

• A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
  NCT06686615 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
  NCT05430828 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female)
• The FOCUS-ADHF Registry
  NCT06726109 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Rivoli, Italy?

5 recruiting trials have at least one study site in Rivoli, Italy.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.